Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Jul;70(825):469–474. doi: 10.1136/pgmj.70.825.469

Screening for colorectal cancer.

D H Bennett 1, J D Hardcastle 1
PMCID: PMC2397665  PMID: 7937423

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlercreutz H., Liewendahl K., Virkola P. Evaluation of Fecatest, a new guaiac test for occult blood in feces. Clin Chem. 1978 May;24(5):756–761. [PubMed] [Google Scholar]
  2. Ahlquist D. A., McGill D. B., Fleming J. L., Schwartz S., Wieand H. S., Rubin J., Moertel C. G. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer. 1989 May 1;63(9):1826–1830. doi: 10.1002/1097-0142(19900501)63:9<1826::aid-cncr2820630928>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  3. Ahlquist D. A., McGill D. B., Schwartz S., Taylor W. F., Owen R. A. Fecal blood levels in health and disease. A study using HemoQuant. N Engl J Med. 1985 May 30;312(22):1422–1428. doi: 10.1056/NEJM198505303122204. [DOI] [PubMed] [Google Scholar]
  4. Allison J. E., Feldman R., Tekawa I. S. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting. Ann Intern Med. 1990 Mar 1;112(5):328–333. doi: 10.7326/0003-4819-112-5-328. [DOI] [PubMed] [Google Scholar]
  5. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1993. CA Cancer J Clin. 1993 Jan-Feb;43(1):7–26. doi: 10.3322/canjclin.43.1.7. [DOI] [PubMed] [Google Scholar]
  6. Burkitt D. P. Epidemiology of cancer of the colon and rectum. Cancer. 1971 Jul;28(1):3–13. doi: 10.1002/1097-0142(197107)28:1<3::aid-cncr2820280104>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  7. Eide T. J. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer. 1986 Aug 15;38(2):173–176. doi: 10.1002/ijc.2910380205. [DOI] [PubMed] [Google Scholar]
  8. Feneyrou B., Bories P., Pomier-Layrargues G., Michel H. Discrepancy in results from three guaiacum resin tests. Br Med J (Clin Res Ed) 1982 Jan 23;284(6311):235–236. doi: 10.1136/bmj.284.6311.235-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frommer D., Logue T. Comparison of five guaiac resin paper tests for demonstrating the presence of blood in faeces. Aust N Z J Med. 1981 Oct;11(5):494–496. doi: 10.1111/j.1445-5994.1981.tb04617.x. [DOI] [PubMed] [Google Scholar]
  10. Greegor D. H. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA. 1967 Sep 18;201(12):943–945. [PubMed] [Google Scholar]
  11. HERTZ R. E., DEDDISH M. R., DAY E. Value of periodic examinations in detecting cancer of the rectum and colon. Postgrad Med. 1960 Mar;27:290–294. doi: 10.1080/00325481.1960.11712835. [DOI] [PubMed] [Google Scholar]
  12. Hardcastle J. D., Thomas W. M., Chamberlain J., Pye G., Sheffield J., James P. D., Balfour T. W., Amar S. S., Armitage N. C., Moss S. M. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989 May 27;1(8648):1160–1164. doi: 10.1016/s0140-6736(89)92750-5. [DOI] [PubMed] [Google Scholar]
  13. Kewenter J., Björk S., Haglind E., Smith L., Svanvik J., Ahrén C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer. 1988 Aug 1;62(3):645–651. doi: 10.1002/1097-0142(19880801)62:3<645::aid-cncr2820620333>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  14. Kinzler K. W., Nilbert M. C., Vogelstein B., Bryan T. M., Levy D. B., Smith K. J., Preisinger A. C., Hamilton S. R., Hedge P., Markham A. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science. 1991 Mar 15;251(4999):1366–1370. doi: 10.1126/science.1848370. [DOI] [PubMed] [Google Scholar]
  15. Kronborg O., Fenger C., Olsen J., Bech K., Søndergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol. 1989 Jun;24(5):599–606. doi: 10.3109/00365528909093096. [DOI] [PubMed] [Google Scholar]
  16. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  17. Morson B. C. Evolution of cancer of the colon and rectum. Cancer. 1974 Sep;34(3):suppl–suppl:849. doi: 10.1002/1097-0142(197409)34:3+<845::aid-cncr2820340710>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  18. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991 Aug 9;253(5020):665–669. doi: 10.1126/science.1651563. [DOI] [PubMed] [Google Scholar]
  19. Pye G., Jackson J., Thomas W. M., Hardcastle J. D. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Br J Surg. 1990 Jun;77(6):630–631. doi: 10.1002/bjs.1800770612. [DOI] [PubMed] [Google Scholar]
  20. Ransohoff D. F., Lang C. A. Screening for colorectal cancer. N Engl J Med. 1991 Jul 4;325(1):37–41. doi: 10.1056/NEJM199107043250107. [DOI] [PubMed] [Google Scholar]
  21. Robinson M. H., Marks C. G., Farrands P. A., Thomas W. M., Hardcastle J. D. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br J Surg. 1994 Mar;81(3):448–451. doi: 10.1002/bjs.1800810343. [DOI] [PubMed] [Google Scholar]
  22. Selby J. V., Friedman G. D., Collen M. F. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. J Clin Epidemiol. 1988;41(5):427–434. doi: 10.1016/0895-4356(88)90043-1. [DOI] [PubMed] [Google Scholar]
  23. Selby J. V., Friedman G. D., Quesenberry C. P., Jr, Weiss N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992 Mar 5;326(10):653–657. doi: 10.1056/NEJM199203053261001. [DOI] [PubMed] [Google Scholar]
  24. Simon J. B. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology. 1985 Mar;88(3):820–837. doi: 10.1016/0016-5085(85)90158-1. [DOI] [PubMed] [Google Scholar]
  25. Slaney G. Results of treatment of carcinoma of the colon and rectum. Mod Trends Surg. 1971;3:69–89. [PubMed] [Google Scholar]
  26. St John D. J., Young G. P., McHutchison J. G., Deacon M. C., Alexeyeff M. A. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Ann Intern Med. 1992 Sep 1;117(5):376–382. doi: 10.7326/0003-4819-117-5-376. [DOI] [PubMed] [Google Scholar]
  27. Stower M. J., Hardcastle J. D. The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital. Eur J Surg Oncol. 1985 Jun;11(2):119–123. [PubMed] [Google Scholar]
  28. Thomas W. M., Pye G., Hardcastle J. D., Walker A. R. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult. Br J Surg. 1992 Aug;79(8):833–835. doi: 10.1002/bjs.1800790842. [DOI] [PubMed] [Google Scholar]
  29. Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Preisinger A. C., Leppert M., Nakamura Y., White R., Smits A. M., Bos J. L. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525–532. doi: 10.1056/NEJM198809013190901. [DOI] [PubMed] [Google Scholar]
  30. Winawer S. J., Prorok P., Macrae F., Bralow S. P. Surveillance and early diagnosis of colorectal cancer. Cancer Detect Prev. 1985;8(3):373–392. [PubMed] [Google Scholar]
  31. Winawer S. J., Schottenfeld D., Flehinger B. J. Colorectal cancer screening. J Natl Cancer Inst. 1991 Feb 20;83(4):243–253. doi: 10.1093/jnci/83.4.243. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES